What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.73%
Annual Rate
NOK 0.80Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
May 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.51BNOK
485.62M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
29.92x
vs Conglomerates peers
Updated Aug 21, 2026
Revenue (TTM)
7.30BNOK
785.57M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
2.47%
vs Conglomerates peers
Updated Aug 21, 2026
Beta
0.4390x
vs all stocks
Updated Aug 21, 2026
52-Week Change
20.86%
vs all stocks
Updated Aug 21, 2026
Forward Annual Dividend Yield
0.73%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
4.51BNOK
485.62M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
6.24BNOK
671.38M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
29.92x
vs Conglomerates peers
Updated Aug 21, 2026
Forward P/E
14.25x
vs Conglomerates peers
Updated Aug 21, 2026
PEG Ratio
-0.0894x
vs Conglomerates peers
Updated Aug 21, 2026
Price to Sales (TTM)
0.7791x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.62×.Updated Aug 21, 2026
Price to Book (MRQ)
2.35x
vs Conglomerates peers
Updated Aug 21, 2026
Enterprise to Revenue
0.8550x
vs Conglomerates peers
Updated Aug 21, 2026
Enterprise to EBITDA
11.12x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 8.11×.Updated Aug 21, 2026
Gross Margin
36.93%
vs Conglomerates peers
Updated Aug 21, 2026
Profit Margin
2.47%
vs Conglomerates peers
Updated Aug 21, 2026
Operating Margin
3.14%
vs Conglomerates peers
Updated Aug 21, 2026
Return on Assets (TTM)
3.61%
vs Conglomerates peers
Updated Aug 21, 2026
Return on Equity (TTM)
7.83%
vs Conglomerates peers
Updated Aug 21, 2026
Revenue (TTM)
7.30BNOK
785.57M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
144.56NOKUpdated Aug 21, 2026
Quarterly Revenue Growth
102.10%
vs Conglomerates peers
Updated Aug 21, 2026
Gross Profit (TTM)
2.56BNOK
275.03M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
769.30MNOK
82.81M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
180.30MNOK
19.41M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
102.14%
vs Conglomerates peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
726.30MNOK
78.18M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
652.75MNOK
70.26M · vs all stocks (USD)
Updated Aug 21, 2026
Forward Annual Dividend Rate
0.8000NOKUpdated Aug 21, 2026
Forward Annual Dividend Yield
0.73%
vs all stocks
Updated Aug 21, 2026
Trailing Annual Dividend Rate
0.8000NOKUpdated Aug 21, 2026
Trailing Annual Dividend Yield
0.73%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 21.56%.Updated Aug 21, 2026
Minority Interest (Equity)
3.00MNOKFY2025 · Dec 31, 2025
Revenue
6.42BNOKFY2025 · Dec 31, 2025
Cost of Goods Sold
4.12BNOKFY2025 · Dec 31, 2025
Gross Profit
2.31BNOKFY2025 · Dec 31, 2025
Operating Income
325.70MNOK
35.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
170.80MNOKFY2025 · Dec 31, 2025
Income Tax Expense
32.90MNOKFY2025 · Dec 31, 2025
Net Income
137.90MNOKFY2025 · Dec 31, 2025
EBIT
345.80MNOKFY2025 · Dec 31, 2025
EBITDA (Income Statement)
679.00MNOKFY2025 · Dec 31, 2025
Other Operating Expenses
509.30MNOKFY2025 · Dec 31, 2025
Non-operating Interest Income
20.40MNOKFY2025 · Dec 31, 2025
Non-operating Interest Expense
175.00MNOKFY2025 · Dec 31, 2025
EPS (Basic)
2.73NOKFY2025 · Dec 31, 2025
EPS (Diluted)
2.73NOKFY2025 · Dec 31, 2025
Basic Shares Outstanding
50.33MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
50.33MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
137.90MNOKFY2025 · Dec 31, 2025
Minority Interests (P&L)
-700.00KNOKFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00NOKFY2025 · Dec 31, 2025
Operating Cash Flow
646.60MNOKFY2025 · Dec 31, 2025
Free Cash Flow
601.10MNOKFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.09BNOKFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
137.90MNOKFY2025 · Dec 31, 2025
Other Non-cash Items
508.70MNOKFY2025 · Dec 31, 2025
Capital Expenditures
-45.50MNOKFY2025 · Dec 31, 2025
Net Acquisitions
-278.60MNOKFY2025 · Dec 31, 2025
Sale of Investments
0.00NOKFY2025 · Dec 31, 2025
Other Investing Activity
-300.00KNOKFY2025 · Dec 31, 2025
Net Investing Cash Flow
-324.40MNOKFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.00BNOKFY2025 · Dec 31, 2025
Long-term Debt Payments
-708.30MNOKFY2025 · Dec 31, 2025
Common Stock Repurchase
-26.00MNOKFY2025 · Dec 31, 2025
Other Financing Charges
-200.00KNOKFY2025 · Dec 31, 2025
Net Financing Cash Flow
632.20MNOKFY2025 · Dec 31, 2025
Shares Outstanding
51.07MSharesUpdated Aug 21, 2026
Float Shares
31.15MSharesUpdated Aug 21, 2026
% Held by Insiders
47.17%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
12.62%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
1.01BNOK
109.21M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
19.82NOKUpdated Aug 21, 2026
Total Debt (MRQ)
1.62BNOK
174.00M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.6667x
vs Conglomerates peers
Updated Aug 21, 2026
Current Ratio (MRQ)
0.9710x
vs Conglomerates peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
47.28NOKUpdated Aug 21, 2026
Total Assets
6.25BNOK
672.21M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.54BNOKFY2025 · Dec 31, 2025
Total Liabilities
3.89BNOKFY2025 · Dec 31, 2025
Total Non-current Assets
3.71BNOKFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.66BNOKFY2025 · Dec 31, 2025
Total Current Liabilities
2.24BNOKFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.28BNOKFY2025 · Dec 31, 2025
Accounts Receivable
1.07BNOKFY2025 · Dec 31, 2025
Inventory
80.00MNOKFY2025 · Dec 31, 2025
Accounts Payable
922.00MNOKFY2025 · Dec 31, 2025
Short-term Debt
156.00MNOKFY2025 · Dec 31, 2025
Other Current Liabilities
816.00MNOKFY2025 · Dec 31, 2025
Long-term Debt
1.40BNOKFY2025 · Dec 31, 2025
Other Non-current Liabilities
105.00MNOKFY2025 · Dec 31, 2025
Common Stock (Book)
25.00MNOKFY2025 · Dec 31, 2025
Retained Earnings
145.00MNOKFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.35BNOK
253.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00NOKFY2025 · Dec 31, 2025
52-Week Low
81.10NOKUpdated Aug 21, 2026
52-Week High
126.00NOKUpdated Aug 21, 2026
52-Week Change
20.86%
vs all stocks
Updated Aug 21, 2026
Beta
0.4390x
vs all stocks
Updated Aug 21, 2026
50-Day MA
113.88NOKUpdated Aug 21, 2026
200-Day MA
103.75NOKUpdated Aug 21, 2026
Avg 10-Day Volume
132.12KSharesUpdated Aug 21, 2026
Avg 30-Day Volume
76.01KSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
3.71NOKUpdated Aug 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.99: grey zoneSignificant
Altman Z-Score: 1.99
High earnings qualityNotable
Earnings Quality Score: 2.78
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $785.57M, above the global median of $520.53MNotable